Ronald Pierson

Erasmus Universiteit Rotterdam, Rotterdam, South Holland, Netherlands

Are you Ronald Pierson?

Claim your profile

Publications (34)196.1 Total impact

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study aimed to examine global and regional cerebral blood flow and amyloid burden in combat veterans with and without traumatic brain injury (TBI). Cerebral blood flow (in milliliters per minute per 100 mL) was measured by quantitative [(15)O]water, and amyloid burden was measured by [(11)C]PIB imaging. Mean global cerebral blood flow was significantly lower in veterans with TBI compared with non-TBI veterans. There were essentially no differences between groups for globally normalized regional cerebral blood flow. Amyloid burden did not differ between TBI and non-TBI veterans. Veterans who have suffered a TBI have significantly lower cerebral blood flow than non-TBI controls but did not manifest increased levels of amyloid, globally or regionally.
    Full-text · Article · Nov 2015 · The Journal of Neuropsychiatry and Clinical Neurosciences
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: It has been estimated that 10%-20% of U.S. veterans of the wars in Iraq and Afghanistan experienced mild traumatic brain injury (TBI), mostly secondary to blast exposure. Diffusion tensor imaging (DTI) may detect subtle white matter changes in both the acute and chronic stages of mild TBI and thus has the potential to detect white matter damage in patients with TBI. The authors used DTI to examine white matter integrity in a relatively large group of veterans with a history of mild TBI. Method: DTI images from 72 veterans of the wars in Iraq and Afghanistan who had mild TBI were compared with DTI images from 21 veterans with no exposure to TBI during deployment. Conventional voxel-based analysis as well as a method of identifying spatially heterogeneous areas of decreased fractional anisotropy ("potholes") were used. Veterans also underwent psychiatric and neuropsychological assessments. Results: Voxel-based analysis did not reveal differences in DTI parameters between the veterans with mild TBI and those with no TBI. However, the veterans with mild TBI had a significantly higher number of potholes than those without TBI. The difference in the number of potholes was not influenced by age, time since trauma, a history of mild TBI unrelated to deployment, or coexisting psychopathology. The number of potholes was correlated with the severity of TBI and with performance in executive functioning tasks. Conclusions: Veterans who had blast-related mild TBI showed evidence of multifocal white matter abnormalities that were associated with severity of the injury and with relevant functional measures. Overall, white matter potholes may constitute a sensitive biomarker of axonal injury that can be identified in mild TBI at acute and chronic stages of its clinical course.
    Full-text · Article · Dec 2012 · American Journal of Psychiatry
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Wernicke encephalopathy and Korsakoff syndrome (the combined disorder is named Wernicke-Korsakoff syndrome [WKS]) are preventable, life-threatening neuropsychiatric syndromes resulting from thiamine deficiency. WKS has historically been associated with alcoholism; more recently, it has been recognized in patients who have anorexia nervosa or have undergone bariatric surgery for obesity. However, patients with nutritional deficiencies of any origin are at risk for WKS. We present clinical histories and neuroimaging data on 2 young adults with underlying psychiatric disorders who became malnourished and developed WKS. A young woman with bipolar disorder and somatization disorder was hospitalized for intractable vomiting. A young man with chronic paranoid schizophrenia developed delusions that food and water were harmful, and was hospitalized after subsisting for 4 months on soda pop. Acute, life-threatening Wernicke encephalopathy was confirmed in both patients by brain magnetic resonance imaging showing classic thalamic injury. The patients were left with persistent cognitive and physical disabilities that were consistent with Korsakoff syndrome. Failure to suspect a vitamin deficiency led to permanent cognitive and physical disabilities that may necessitate lifelong care for these patients. The neuropsychiatric consequences could have been prevented by prompt recognition of their thiamine deficiency.
    Full-text · Article · Nov 2011 · Cognitive and behavioral neurology: official journal of the Society for Behavioral and Cognitive Neurology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Previous neuroimaging research indicates that brain atrophy in Huntington disease (HD) begins many years before movement abnormalities become severe enough to warrant diagnosis. Most clinical trials being planned for individuals in the prediagnostic stage of HD propose to use delay of disease onset as the primary outcome measure. Although formulas have been developed based on age and CAG repeat length, to predict when HD motor onset will occur, it would be useful to have additional measures that can improve the accuracy of prediction of disease onset. The current study examined magnetic resonance imaging (MRI) measures of striatum and white matter volume in 85 individuals prospectively followed from pre-HD stage through diagnosable motor onset (incident cases) and 85 individuals individually matched with incident cases on CAG repeat length, sex, and age, who were not diagnosed with HD during the course of the study. Volumes of striatum and white matter were significantly smaller in individuals who would be diagnosed 1 to 4 years following the initial MRI scan, compared with those who would remain in the pre-HD stage. Putamen volume was the measure that best distinguished between the two groups. Results suggest that MRI volumetric measures may be helpful in selecting individuals for future clinical trials in pre-HD where HD motor onset is the primary outcome measure. In planning for multisite clinical trials in pre-HD, investigators may also want to consider using more objective measures, such as MRI volumes, in addition to onset of diagnosable movement disorder, as major outcome measures.
    Full-text · Article · Sep 2011 · Biological psychiatry
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Schizophrenia has a characteristic onset during adolescence or young adulthood but also tends to persist throughout life. Structural magnetic resonance studies indicate that brain abnormalities are present at onset, but longitudinal studies to assess neuroprogression have been limited by small samples and short or infrequent follow-up intervals. The Iowa Longitudinal Study is a prospective study of 542 first-episode patients who have been followed up to 18 years. In this report, we focus on those patients (n = 202) and control subjects (n = 125) for whom we have adequate structural magnetic resonance data (n = 952 scans) to provide a relatively definitive determination of whether progressive brain change occurs over a time interval of up to 15 years after intake. A repeated-measures analysis showed significant age-by-group interaction main effects that represent a significant decrease in multiple gray matter regions (total cerebral, frontal, thalamus), multiple white matter regions (total cerebral, frontal, temporal, parietal), and a corresponding increase in cerebrospinal fluid (lateral ventricles and frontal, temporal, and parietal sulci). These changes were most severe during the early years after onset. They occur at severe levels only in a subset of patients. They are correlated with cognitive impairment but only weakly with other clinical measures. Progressive brain change occurs in schizophrenia, affects both gray matter and white matter, is most severe during the early stages of the illness, and occurs only in a subset of patients. Measuring severity of progressive brain change offers a promising new avenue for phenotype definition in genetic studies of schizophrenia.
    Preview · Article · Jul 2011 · Biological psychiatry
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Longer CAG repeat length is associated with faster clinical progression in Huntington disease, although the effect of higher repeat length on brain atrophy is not well documented. Striatal volumes were obtained from MRI scans of 720 individuals with prodromal Huntington disease. Striatal volume was plotted against age separately for groups with CAG repeat lengths of 38-39, 40, 41, 42, 43, 44, 45, 46, and 47-54. Slopes representing the association between age and striatal volume were significantly steeper as CAG repeat length increased. Although cross-sectional, these data suggest that striatal atrophy, like clinical progression, may occur faster with higher CAG repeat lengths.
    No preview · Article · May 2011 · PLoS Currents
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Progressive brain volume changes in schizophrenia are thought to be due principally to the disease. However, recent animal studies indicate that antipsychotics, the mainstay of treatment for schizophrenia patients, may also contribute to brain tissue volume decrement. Because antipsychotics are prescribed for long periods for schizophrenia patients and have increasingly widespread use in other psychiatric disorders, it is imperative to determine their long-term effects on the human brain. To evaluate relative contributions of 4 potential predictors (illness duration, antipsychotic treatment, illness severity, and substance abuse) of brain volume change. Predictors of brain volume changes were assessed prospectively based on multiple informants. Data from the Iowa Longitudinal Study. Two hundred eleven patients with schizophrenia who underwent repeated neuroimaging beginning soon after illness onset, yielding a total of 674 high-resolution magnetic resonance scans. On average, each patient had 3 scans (≥2 and as many as 5) over 7.2 years (up to 14 years). Brain volumes. During longitudinal follow-up, antipsychotic treatment reflected national prescribing practices in 1991 through 2009. Longer follow-up correlated with smaller brain tissue volumes and larger cerebrospinal fluid volumes. Greater intensity of antipsychotic treatment was associated with indicators of generalized and specific brain tissue reduction after controlling for effects of the other 3 predictors. More antipsychotic treatment was associated with smaller gray matter volumes. Progressive decrement in white matter volume was most evident among patients who received more antipsychotic treatment. Illness severity had relatively modest correlations with tissue volume reduction, and alcohol/illicit drug misuse had no significant associations when effects of the other variables were adjusted. Viewed together with data from animal studies, our study suggests that antipsychotics have a subtle but measurable influence on brain tissue loss over time, suggesting the importance of careful risk-benefit review of dosage and duration of treatment as well as their off-label use.
    Preview · Article · Feb 2011 · Archives of general psychiatry
  • [Show abstract] [Hide abstract]
    ABSTRACT: The BRAINS (Brain Research: Analysis of Images, Networks, and Systems) image analysis software has been in use, and in constant development, for over 20 years. The original neuroimage analysis pipeline using BRAINS was designed as a semiautomated procedure to measure volumes of the cerebral lobes and subcortical structures, requiring manual intervention at several stages in the process. Through use of advanced image processing algorithms the need for manual intervention at stages of image realignment, tissue sampling, and mask editing have been eliminated. In addition, inhomogeneity correction, intensity normalization, and mask cleaning routines have been added to improve the accuracy and consistency of the results. The fully automated method, AutoWorkup, is shown in this study to be more reliable (ICC ≥ 0.96, Jaccard index ≥ 0.80, and Dice index ≥ 0.89 for all tissues in all regions) than the average of 18 manual raters. On a set of 1130 good quality scans, the failure rate for correct realignment was 1.1%, and manual editing of the brain mask was required on 4% of the scans. In other tests, AutoWorkup is shown to produce measures that are reliable for data acquired across scanners, scanner vendors, and across sequences. Application of AutoWorkup for the analysis of data from the 32-site, multivendor PREDICT-HD study yield estimates of reliability to be greater than or equal to 0.90 for all tissues and regions.
    No preview · Article · Jan 2011 · NeuroImage
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Neuroimaging studies of subjects who are gene-expanded for Huntington Disease, but not yet diagnosed (termed prodromal HD), report that the cortex is "spared," despite the decrement in striatal and cerebral white-matter volume. Measurement of whole-cortex volume can mask more subtle, but potentially clinically relevant regional changes in volume, thinning, or surface area. The current study addressed this limitation by evaluating cortical morphology of 523 prodromal HD subjects. Participants included 693 individuals enrolled in the PREDICT-HD protocol. Of these participants, 523 carried the HD gene mutation (prodromal HD group); the remaining 170 were non gene-expanded and served as the comparison group. Based on age and CAG repeat length, gene-expanded subjects were categorized as "Far from onset," "Midway to onset," "Near onset," and "already diagnosed." MRI scans were processed using FreeSurfer. Cortical volume, thickness, and surface area were not significantly different between the Far from onset group and controls. However, beginning in the Midway to onset group, the cortex showed significant volume decrement, affecting most the posterior and superior cerebral regions. This pattern progressed when evaluating the groups further into the disease process. Areas that remained mostly unaffected included ventral and medial regions of the frontal and temporal cortex. Morphologic changes were mostly in thinning as surface area did not substantially change in most regions. Early in the course of HD, the cortex shows changes that are manifest as cortical thinning and are most robust in the posterior and superior regions of the cerebrum.
    Full-text · Article · Dec 2010 · Neurobiology of Disease
  • Source

    Full-text · Article · Oct 2010 · Journal of the American Society for Experimental NeuroTherapeutics
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Huntington's disease is an autosomal dominant brain disease. Although conceptualized as a neurodegenerative disease of the striatum, a growing number of studies challenge this classic concept of Huntington's disease aetiology. Intracranial volume is the tissue and fluid within the calvarium and is a representation of the maximal brain growth obtained during development. The current study reports intracranial volume obtained from an magnetic resonance imaging brain scan in a sample of subjects (n = 707) who have undergone presymptomatic gene testing. Participants who are gene-expanded but not yet manifesting the disease (prodromal Huntington's disease) are compared with subjects who are non-gene expanded. The prodromal males had significantly smaller intracranial volume measures with a mean volume that was 4% lower compared with controls. Although the prodromal females had smaller intracranial volume measures compared with their controls, this was not significant. The current findings suggest that mutant huntingtin can cause abnormal development, which may contribute to the pathogenesis of Huntington's disease.
    Full-text · Article · Oct 2010 · Brain
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: As therapeutics are being developed to target the underlying neuropathology of Huntington disease, interest is increasing in methodologies for conducting clinical trials in the prodromal phase. This study was designed to examine the potential utility of structural MRI measures as outcome measures for such trials. Data are presented from 211 prodromal individuals and 60 controls, scanned both at baseline and at the 2-year follow-up. Prodromal participants were divided into groups based on proximity to estimated onset of diagnosable clinical disease: far (>15 years from estimated onset), mid (9-15 years) and near (<9 years). Volumetric measurements of caudate, putamen, total striatum, globus pallidus, thalamus, total grey and white matter and cerebrospinal fluid were performed. All prodromal groups showed a faster rate of atrophy than controls in striatum, total brain and cerebral white matter (especially in the frontal lobe). Neither prodromal participants nor controls showed any significant longitudinal change in cortex (either total cortical grey or within individual lobes). When normal age-related atrophy (ie, change observed in the control group) was taken into account, there was more statistically significant disease-related atrophy in white matter than in striatum. Measures of volume change in striatum and white-matter volume, particularly in the frontal lobe, may serve as excellent outcome measures for future clinical trials in prodromal Huntington disease. Clinical trials using white matter or striatal volume change as an outcome measure will be most efficient if the sample is restricted to individuals who are within 15 years of estimated onset of diagnosable disease.
    Full-text · Article · Sep 2010 · Journal of neurology, neurosurgery, and psychiatry
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Previous MRI studies with participants prior to manifest Huntington disease have been conducted in small single-site samples. The current study reports data from a systematic multi-national study during the prodromal period of Huntington disease and examines whether various brain structures make unique predictions about the proximity to manifest disease. MRI scans were acquired from 657 participants enrolled at 1 of 32 PREDICT-HD research sites. Only prodromal Huntington disease participants (those not meeting motor criteria for diagnosis) were included and subgrouped by estimated diagnosis proximity (Near, Mid, and Far) based upon a formula incorporating age and CAG-repeat length. Results show volumes of all three subgroups differed significantly from Controls for total brain tissue, cerebral spinal fluid, white matter, cortical gray matter, thalamus, caudate, and putamen. Total striatal volume demonstrated the largest differences between Controls and all three prodromal subgroups. Cerebral white matter offered additional independent power in the prediction of estimated proximity to diagnosis. In conclusion, this large cross-sectional study shows that changes in brain volume are detectable years to decades prior to estimated motor diagnosis of Huntington disease. This suggests that a clinical trial of a putative neuroprotective agent could begin as much as 15 years prior to estimated motor diagnosis in a cohort of persons at risk for but not meeting clinical motor diagnostic criteria for Huntington disease, and that neuroimaging (striatal and white matter volumes) may be among the best predictors of diagnosis proximity.
    Full-text · Article · Apr 2010 · Brain research bulletin

  • No preview · Article · Jan 2010 · Neurotherapeutics
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The cerebellum is a brain region recognized primarily in the coordination of movement and related accessory motor functions. In addition, emerging evidence implicates the cerebellum in cognitive processes and suggests that this brain region might be subject to experience-dependent changes in structure. Therefore, the aim of this study was to evaluate the role of early environmental deprivation in the maturation of the cerebellum and aspects of cognitive development. Structural magnetic resonance imaging volumes of 12 cerebellar sub-regions from 31 previously neglected and 30 typically developing children were compared with subjects' corresponding neuropsychological test scores. Neglected children had smaller volume of the superior-posterior cerebellar lobes. Moreover, superior-posterior lobe volume was found to mediate neuropsychological test performance differences between groups, with larger volumes yielding better outcomes on tests of memory and planning. These data support the importance of experience-dependent changes in cerebellar structure and highlight the role of the cerebellum in higher cognitive functions.
    Full-text · Article · Sep 2009 · Biological psychiatry
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Single task analysis methods of functional MRI brain data, though useful, are not able to evaluate the joint information between tasks. Data fusion of multiple tasks that probe different cognitive processes provides knowledge of the joint information and may be important in order to better understand complex disorders such as schizophrenia. In this article, we introduce a simple but effective technique to fuse two tasks by computing the histogram of correlations for all possible combinations of whole brain voxels. The approach was applied to data derived from healthy controls and patients with schizophrenia from four different tasks, auditory oddball (target), auditory oddball (novel), Sternberg working memory, and sensorimotor. It was found that in four out of six task combinations patients' intertask correlations were more positively correlated than controls', in one combination the controls showed more positive correlations and in another there was no significant difference. The robustness of this result was checked with several testing techniques. The four task combinations for which patients had more positive correlation occurred at different scanning sessions and the task combination that showed the opposite result occurred within the same scanning session. Brain regions that showed high intertask correlations were found for both groups and regions that correlated differently between the two groups were identified. The approach introduced finds interesting results and new differential features that cannot be achieved through traditional methods.
    Full-text · Article · Aug 2009 · Human Brain Mapping

  • No preview · Article · Jul 2009 · NeuroImage
  • EH Aylward · PC Nopoulos · RK Pierson · CA Ross · JS Paulsen

    No preview · Article · Jul 2009 · NeuroImage

  • No preview · Article · Jul 2009 · NeuroImage
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction Huntington's Disease (HD) is an autosomal dominant degenerative brain disorder. The discovery of the CAG repeat expansion in the huntingtin gene has allowed a unique opportunity to study subjects who undergo presymptomatic testing for the disease, evaluating the evolution of disease development. The length of the CAG repeat expansion is highly correlated with age of onset of diagnosable HD, making possible the prediction of the approximate time to onset for presymptomatic subjects. The PREDICT-HD study is an international 30-site study of preHD subjects and includes assessment of brain morphology using quantitative structural MRI, comparing volumes of brain regions and tissues between preHD gene-expanded subjects compared to subjects who tested gene non-expanded. The aim of this study was to evaluate both global and regional brain structure, and by dividing subjects into prognostic groups based on CAG repeat length and current age, determining when these abnormalities appear. Methods The sample consists of 652 subjects: 146 gene-non-expanded and 506 gene-expanded subjects. Gene-expanded subjects are divided into three prognostic group: ‘far- from-onset’ (> 15 years) ‘midway-to-onset’ (between 9 and 15 years), and ‘near-to-onset’ (within the next 8 years). Mean subject age was 42.6 (SD = 10.27, range 19.1 to 77.8). Scans were obtained using a standard multi-mode protocol with an axial 3D volumetric spoiled gradient echo series (∼1×1×1.5 mm voxels) and a dual echo PDT2 (∼1×1×3 mm voxels) series. All sites used a General Electric 1.5 Tesla scanner (with the exception of two sites using a 1.5 Tesla Siemens scanner). Brain measures were obtained with a fully automated method using BRAINS2 software. All measures were expressed as ratios of intracranial volume. Age, gender, and scanner-to-scanner variation were statistically controlled. Results Brain measures that were found to be substantially different in the preHD subjects compared to controls include decrements in volume of total brain, cerebral white and gray matter (cortex), caudate, putamen and thalamus with accompanying increase in CSF volume. The only brain measure showing no significant structural difference was the cerebellum. Importantly, every brain measure was found to be abnormal for every prognostic group meaning that as far back as we can look (>15 years to predicted onset), the brain is substantially abnormal in structure. Table 1 illustrates relative effect sizes for each brain measure found to be abnormal. The striatum (especially the putamen) had the largest effect sizes. Cerebral white matter showed significant structural abnormality in comparison to a very modest difference between groups for the cerebral cortex. Conclusions The current study supports the conception of HD as a brain disease, with striatal selectivity, but with widespread degeneration. Although the striatum is indeed abnormal, so is every other tissue measured, the exception being the cerebellum. In addition, these abnormalities are detected in subjects who are far from onset. Although etiology cannot be determined from this study, significant structural brain abnormality detected greater than 15 years from disease onset is suggestive of either an extremely long degenerative process or possibly a combination of abnormal developmental processes followed by degeneration. Copyright © 2009 Elsevier Inc. All rights reserved.
    No preview · Article · Jul 2009 · NeuroImage

Publication Stats

2k Citations
196.10 Total Impact Points

Institutions

  • 2012
    • Erasmus Universiteit Rotterdam
      • Department of Child and Adolescent Psychiatry
      Rotterdam, South Holland, Netherlands
  • 2007-2011
    • University of Iowa Children's Hospital
      Iowa City, Iowa, United States
  • 2000-2011
    • University of Iowa
      • Department of Psychiatry
      Iowa City, Iowa, United States